Figure 1

COPD exacerbations during the FORWARD study in patients stratified by different baseline characteristics. (a) Use of tiotropium before study entry; data from Wedzicha et al.²⁸ (b) Percentage count of baseline blood eosinophils; data on file. BDP/FF, beclometasone dipropionate/formoterol.